Skip to content

Franconian Longitudinal Study of Anorexia Nervosa in Adolescents - Intervention Module

Franconian Longitudinal Study of Anorexia Nervosa in Adolescents - Intervention Module - FRALANA-I

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00024675
Enrollment
63
Registered
2021-04-28
Start date
2021-05-03
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Dissatisfaction F50.0 F50.1

Interventions

Group 1: Body confrontation intervention on a PC (4 sessions) [AN-INT (randomized allocation)
body dissatisfied control group] Group 2: Treatment as usual [AN-TAU (randomized allocation)]

Sponsors

Universitätsklinikum Erlangen Kinder- und Jugendabteilung für Psychische Gesundheit
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
10 Years to 21 Years

Inclusion criteria

Inclusion criteria: Gender: female; age: 10 -21 years; groups: (a) AN-INT / AN-TAU: F50.0G or 50.1G following ICD-10 criteria, (b) control group (body dissatisfied): EDI-2 subscale "Body Dissatisfaction" PR = 75 & clinically relevant body dissatisfaction; weight: BMI > 10th age percentile or >18.5, respectively; treatment: ongoing treatment in a child- and adolescent psychiatric or psychiatric setting, respectively.

Exclusion criteria

Exclusion criteria: Acute psychotic symptoms; substance abuse or addiction; chronic physiological disorders (especially cardiovascular dieseases); psychiatric medication which has strongly tranquillizing effects (such as Benzodiazepines); learning disabilities; insufficient knowledge of the German language. For the body dissatisfied control group: eating disorder diagnosis.

Design outcomes

Primary

MeasureTime frame
Body dissatisfaction (EDI-2 questionnaire, sub-scale "Body Dissatisfaction", pre-/post-intervention)

Secondary

MeasureTime frame
Body avoidance behaviour (BIAQ questionnaire, pre-/post-intervention); attentional bias (gaze behaviour ROIs [disliked body parts] vs. rest of the body, pre-/post-intervention and pre-/post-session); stress reactivity according to (1) cortisol and (2) a-amylase (level measurements of 4 samples each, per session [+0'/baseline, +10', +30', +60']); heart rate variability (ECG + smart watch during each session)

Countries

Germany

Contacts

Public ContactStefanie Horndasch

Kinder- und Jugendabteilung für Psychische Gesundheit, Universitätsklinikum Erlangen

jp-fralana@uk-erlangen.de09131 85 39123

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026